Board Meeting18 Jul 2026, 04:20 pm
Nath Bio-Genes Board Meeting on July 29 to Approve Q1 FY27 Unaudited Results
AI Summary
Nath Bio-Genes (India) Ltd has announced that its Board of Directors will convene on July 29, 2026. The primary agenda item is to consider, approve, and take on record the unaudited financial results, both standalone and consolidated, for the quarter ended June 30, 2026. The company has also closed its trading window from June 30, 2026, and it will reopen on August 1, 2026, 48 hours after the declaration of these financial results, in compliance with insider trading regulations.
Key Highlights
- Board meeting scheduled for July 29, 2026.
- To approve unaudited financial results for Q1 FY27.
- Trading window closed from June 30, 2026, to July 31, 2026.
- Results to be considered on standalone and consolidated basis.
Price Impact
More from NATHBIOGEN